Lymphoma Clinical Trials in Reggio Emilia, Reggio Emilia
2 recruitingReggio Emilia, Reggio Emilia, Italy
Showing 1–2 of 2 trials
Recruiting
Phase 3
Study of Subcutaneous Epcoritamab in Combination With Intravenous Rituximab and Oral Lenalidomide (R2) to Assess Adverse Events and Change in Disease Activity in Adult Participants With Previously Untreated Follicular Lymphoma
Follicular Lymphoma ( FL)
Genmab1,095 enrolled265 locationsNCT06191744
Recruiting
The Unmet Needs of Cancer Survivors in Ausl IRCCS Reggio Emilia
Breast CancerColorectal, CancerProstate Cancer+5 more
University of Modena and Reggio Emilia45 enrolled1 locationNCT06236373